Free Trial
NASDAQ:XAIR

Beyond Air (XAIR) Stock Price, News & Analysis

Beyond Air logo
$0.49
-0.08 (-14.03%)
(As of 11/1/2024 ET)

About Beyond Air Stock (NASDAQ:XAIR)

Key Stats

Today's Range
$0.48
$0.59
50-Day Range
$0.30
$0.57
52-Week Range
$0.30
$2.61
Volume
787,848 shs
Average Volume
548,208 shs
Market Capitalization
$23.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.67
Consensus Rating
Buy

Company Overview

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Beyond Air Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
91st Percentile Overall Score

XAIR MarketRank™: 

Beyond Air scored higher than 91% of companies evaluated by MarketBeat, and ranked 113th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Beyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Beyond Air has only been the subject of 3 research reports in the past 90 days.

  • Read more about Beyond Air's stock forecast and price target.
  • Earnings Growth

    Earnings for Beyond Air are expected to grow in the coming year, from ($1.03) to ($0.56) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Beyond Air is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Beyond Air is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Beyond Air has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Beyond Air's valuation and earnings.
  • Percentage of Shares Shorted

    2.86% of the outstanding shares of Beyond Air have been sold short.
  • Short Interest Ratio / Days to Cover

    Beyond Air has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Beyond Air has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Beyond Air does not currently pay a dividend.

  • Dividend Growth

    Beyond Air does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.86% of the outstanding shares of Beyond Air have been sold short.
  • Short Interest Ratio / Days to Cover

    Beyond Air has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Beyond Air has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Beyond Air has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Beyond Air this week, compared to 1 article on an average week.
  • Search Interest

    11 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Beyond Air insiders have bought more of their company's stock than they have sold. Specifically, they have bought $793,019.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 31.50% of the stock of Beyond Air is held by institutions.

  • Read more about Beyond Air's insider trading history.
Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

XAIR Stock News Headlines

Nvidia warning urgent
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Short Interest in Beyond Air, Inc. (NASDAQ:XAIR) Increases By 25.0%
Beyond Air files to sell 81.7M shares of common stock for holders
See More Headlines

XAIR Stock Analysis - Frequently Asked Questions

Beyond Air's stock was trading at $1.96 at the beginning of 2024. Since then, XAIR shares have decreased by 75.0% and is now trading at $0.4901.
View the best growth stocks for 2024 here
.

Beyond Air, Inc. (NASDAQ:XAIR) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of ($0.39) by $0.12. The business earned $0.68 million during the quarter, compared to analysts' expectations of $0.72 million. Beyond Air had a negative trailing twelve-month return on equity of 240.15% and a negative net margin of 3,272.46%.

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beyond Air investors own include Pfizer (PFE), NVIDIA (NVDA), General Motors (GM), Meta Platforms (META), Corbus Pharmaceuticals (CRBP), Norwegian Cruise Line (NCLH) and OPKO Health (OPK).

Company Calendar

Last Earnings
8/06/2024
Today
11/02/2024
Next Earnings (Confirmed)
11/11/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:XAIR
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.67
High Stock Price Target
$8.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+648.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-60,240,000.00
Net Margins
-3,272.46%
Pretax Margin
-3,493.83%

Debt

Sales & Book Value

Annual Sales
$1.78 million
Book Value
$0.75 per share

Miscellaneous

Free Float
38,222,000
Market Cap
$23.13 million
Optionable
Optionable
Beta
-0.12
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NASDAQ:XAIR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners